Comorbidity and multimorbidity in medicine today: challenges and opportunities for bringing separated branches of medicine closer to each other.

Comorbidity and multimorbidity represent one of the greatest chalenge to academic medicine. Many disorders are often comorbidly expressed in diverse combinations. In clinical practice comorbidity and multimorbidity are underrecognized, underdiagnosed, underestimated and undertreated. So that one can speak about comorbidity and multimorbidity anosognosia. Comorbidities and multimorbidities are indifferent to medical specializations, so the integrative and complementary medicine is an imperative in the both education and practice. Shifting the paradigm from vertical/mono-morbid interventions to comorbidity and multimorbidity approaches enhances effectiveness and efficiency of human resources utilization. Comorbidity and multimorbidity studies have been expected to be an impetus to research on the validity of current diagnostic systems as well as on establishing more effective and efficient treatment including individualized and personalized pharmacotherapy.

[1]  A R Feinstein,et al.  THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE. , 1970, Journal of chronic diseases.

[2]  L. George,et al.  Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes. , 1984, Archives of general psychiatry.

[3]  T. Widiger,et al.  The influence of classification methods on comorbidity. , 1990 .

[4]  G. Klerman.  Approaches to the phenomena of comorbidity. , 1990 .

[5]  J. Maser,et al.  Comorbidity of mood and anxiety disorders , 1990 .

[6]  Meyer Friedman,et al.  Type A Behavior: Its Diagnosis and Treatment , 1996, Prevention in Practice Library.

[7]  Marjan van den Akker,et al.  Comorbidity or multimorbidity: what's in a name ? A review of literature , 1996 .

[8]  J A Knottnerus,et al.  Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. , 1998, Journal of clinical epidemiology.

[9]  Gin S Malhi, Anthony S Hale,et al.  Comorbidity , 2000, International journal of psychiatry in clinical practice.

[10]  B. Starfield,et al.  Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. , 2002, Archives of internal medicine.

[11]  H. Dreher.  Mind-Body Unity: A New Vision for Mind-Body Science and Medicine , 2003 .

[12]  K. Grumbach.  Chronic Illness, Comorbidities, and the Need for Medical Generalism , 2003, The Annals of Family Medicine.

[13]  L. Bouter,et al.  How to measure comorbidity. a critical review of available methods. , 2003, Journal of clinical epidemiology.

[14]  E. Nunes,et al.  Diagnosing comorbidity: concepts, criteria, and methods , 2004, Acta Neuropsychiatrica.

[15]  Mario Maj,et al.  ‘Psychiatric comorbidity’: an artefact of current diagnostic systems? , 2005, British Journal of Psychiatry.

[16]  Martin Fortin,et al.  Multimorbidity is common to family practice: is it commonly researched? , 2005, Canadian family physician Medecin de famille canadien.

[17]  Martin Fortin,et al.  Prevalence of Multimorbidity Among Adults Seen in Family Practice , 2005, The Annals of Family Medicine.

[18]  G. Ash,et al.  Medical and Psychiatric Comorbidity Over the Course of Life , 2006, British Journal of Psychiatry.

[19]  Carlos A. Zarate,et al.  Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder , 2006, Biological Psychiatry.

[20]  R. Krueger,et al.  Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. , 2006, Annual review of clinical psychology.

[21]  B. Starfield.  Threads and Yarns: Weaving the Tapestry of Comorbidity , 2006, The Annals of Family Medicine.

[22]  A. Steptoe.  Depression and Physical Illness: Integrating clinical with biobehavioural studies of depression and physical illness , 2006 .

[23]  N. Sartorius.  Physical illness in people with mental disorders. , 2007, World psychiatry : official journal of the World Psychiatric Association.

[24]  M. Jakovljevič,et al.  Mental disorders and metabolic syndrome: a fatamorgana or warning reality? , 2007, Psychiatria Danubina.

[25]  John D. Piette,et al.  Beyond Comorbidity Counts: How Do Comorbidity Type and Severity Influence Diabetes Patients’ Treatment Priorities and Self-Management? , 2007, Journal of General Internal Medicine.

[26]  J. Mezzich,et al.  Clinical complexity and person‐centered integrative diagnosis , 2008, World psychiatry : official journal of the World Psychiatric Association.

[27]  M. Jakovljevič.  Transdisciplinary holistic integrative psychiatry - a wishfull thinking or reality? , 2008, Psychiatria Danubina.

[28]  Roberto De Simone,et al.  Towards a definition of comorbidity in the light of clinical complexity , 2008, Neurological Sciences.

[29]  Krin A. Kay,et al.  The implications of human metabolic network topology for disease comorbidity , 2008, Proceedings of the National Academy of Sciences.

[30]  M. Jakovljevič.  Integrating brave new psychiatry of the person, for the person, by the person and with the person: the postmodern turn. , 2008, Psychiatria Danubina.

[31]  F. Grün,et al.  Endocrine disrupters as obesogens , 2009, Molecular and Cellular Endocrinology.

[32]  M. Aragona.  The Role of Comorbidity in the Crisis of the Current Psychiatric Classification System , 2009 .

[33]  M. Aragona.  About and Beyond Comorbidity: Does the Crisis of the DSM Bring on a Radical Rethinking of Descriptive Psychopathology? , 2009 .

[34]  C. E. Dean.  Personalized Medicine: Boon or Budget-Buster? , 2009, The Annals of pharmacotherapy.

[35]  S. Hébert,et al.  Putative Role of MicroRNA-Regulated Pathways in Comorbid Neurological and Cardiovascular Disorders , 2009, Cardiovascular psychiatry and neurology.

[36]  Brian E.Leonard,et al.  Inflammation and depression: Is there a causal connection with dementia? , 2006, Neurotoxicity Research.

[37]  P. Buckley,et al.  Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer , 2009 .

[38]  J. David Sweatt,et al.  Experience-Dependent Epigenetic Modifications in the Central Nervous System , 2009, Biological Psychiatry.

[39]  M. Jakovljevič.  Psychopharmacotherapy and comorbidity: conceptual and epistemiological issues, dilemmas and controversies. , 2009, Psychiatria Danubina.

[40]  James S. Brown.  Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia , 2008, Schizophrenia bulletin.

[41]  B. Starfield,et al.  Defining Comorbidity: Implications for Understanding Health and Health Services , 2009, The Annals of Family Medicine.

[42]  A. Eisch,et al.  Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: Unraveling the genome to understand the mind , 2010, Neurobiology of Disease.

[43]  Miro Jakovljević,et al.  Comorbidity, multimorbidity and personalized psychosomatic medicine: epigenetics rolling on the horizon. , 2010, Psychiatria Danubina.

[44]  David Melzer,et al.  Association of Urinary Bisphenol A Concentration with Heart Disease: Evidence from NHANES 2003/06 , 2010, PloS one.

[45]  M. Hyland,et al.  Network origins of anxiety and depression , 2010, Behavioral and Brain Sciences.

[46]  Hendrik van den Bussche,et al.  Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions , 2010, PloS one.

[47]  L. Hulvershorn,et al.  Toward Early, Personalized, Rational Polypharmacy In Psychiatry: A Tri‐Dimensional Approach , 2010 .

[48]  Robert Adams,et al.  Multimorbidity - not just an older person's issue. Results from an Australian biomedical study , 2010, BMC public health.

[49]  A. Homayouni.  Comparisonal investigation of emotional intelligence in addicted and nonaddicted people , 2011, European Psychiatry.

[50]  Verena D. Schmittmann,et al.  The Small World of Psychopathology , 2011, PloS one.

[51]  R. Dantzer,et al.  Inflammation-associated depression: From serotonin to kynurenine , 2011, Psychoneuroendocrinology.

[52]  Hendrik van den Bussche,et al.  Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany , 2011, BMC public health.

[53]  An Pan,et al.  Bidirectional Association Between Depression and Metabolic Syndrome , 2012, Diabetes Care.

[54]  M. Jakovljevič,et al.  Comorbidity and multimorbidity in patients with schizophrenia and bipolar disorder: similarities and differencies. , 2012, Psychiatria Danubina.

[55]  I. Heuser,et al.  Pathways linking early life stress, metabolic syndrome, and the inflammatory marker fibrinogen in depressed inpatients. , 2012, Psychiatria Danubina.

[56]  M. Jakovljevič,et al.  Comorbidity as an epistemological challenge to modern psychiatry , 2012 .

[57]  S. Stansfeld,et al.  Interrelationship of depression, stress and inflammation in cancer patients: a preliminary study. , 2012, Journal of affective disorders.

[58]  G. Oxenkrug.  Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. , 2013, Current drug targets.

[59]  G. Juckel,et al.  New pathways of increased cardiovascular risk in depression: a pilot study on the association of high-sensitivity C-reactive protein with pro-atherosclerotic markers in patients with depression. , 2013, Journal of affective disorders.